Liver Fluke-Associated Biliary Tract Cancer

키워드

참고문헌 (97)

1. Ustundag Y, "Cholangiocarcinoma: a compact review of the literature", World J Gastroenterol, 14, pp.6458~6466 (2008)[DOI]
2. Jepsen P, "Incidence rates of intra- and extrahepatic cholangiocarcinomas in Denmark from 1978 through 2002", J Natl Cancer Inst, 99, pp.895~897 (2007)[DOI]
3. Doherty B, "Update on the diagnosis and treatment of cholangiocarcinoma", Curr Gastroenterol Rep, 19, pp.2~ (2017)[DOI]
4. Welzel TM, "Impact of classification of hilar cholangiocarcinomas (Klatskin tumors) on the incidence of intra- and extrahepatic cholangiocarcinoma in the United States", J Natl Cancer Inst, 98, pp.873~875 (2006)[DOI]
5. Gatto M, "Cholangiocarcinoma: update and future perspectives", Dig Liver Dis, 42, pp.253~260 (2010)[DOI]
6. Bismuth H, "Management strategies in resection for hilar cholangiocarcinoma", Ann Surg, 215, pp.31~38 (1992)[DOI]
7. Sripa B, "Cholangiocarcinoma: lessons from Thailand", Curr Opin Gastroenterol, 24, pp.349~356 (2008)[DOI]
8. Ehlken H, "Risk of cholangiocarcinoma in patients with primary sclerosing cholangitis: diagnosis and surveillance", Curr Opin Gastroenterol, 33, pp.78~84 (2017)
9. Tyson GL, "Risk factors for cholangiocarcinoma", Hepatology, 54, pp.173~184 (2011)
10. Sripa B, "Opisthorchiasis and Opisthorchis-associated cholangiocarcinoma in Thailand and Laos", Acta Trop, 120(Suppl 1), pp.S158~S168 (2011)[DOI]
11. "Schistosomes, liver flukes and Helicobacter pylori. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Lyon, 7-14 June 1994", IARC Monogr Eval Carcinog Risks Hum, 61, pp.1~241 (1994)
12. Keiser J, "Food-borne trematodiases", Clin Microbiol Rev, 22, pp.466~483 (2009)[DOI]
13. Petney T, "The ecology of the Bithynia first intermediate hosts of Opisthorchis viverrini", Parasitol Int, 61, pp.38~45 (2012)[DOI]
14. Vichasri S, "Opisthorchis viverrini: intensity and rates of infection in cyprinoid fish from an endemic focus in Northeast Thailand", Southeast Asian J Trop Med Public Health, 13, pp.138~141 (1982)
15. Yossepowitch O, "Opisthorchiasis from imported raw fish", Emerg Infect Dis, 10, pp.2122~2126 (2004)[DOI]
16. Kaewpitoon N, "Opisthorchis viverrini: the carcinogenic human liver fluke", World J Gastroenterol, 14, pp.666~674 (2008)[DOI]
17. Enes JE, "Prevalence of Opisthorchis viverrini infection in the canine and feline hosts in three villages, Khon Kaen Province, northeastern Thailand", Southeast Asian J Trop Med Public Health, 41, pp.36~42 (2010)
18. Kaewpitoon N, "Review and current status of Opisthorchis viverrini infection at the community level in Thailand", Asian Pac J Cancer Prev, 16, pp.6825~6830 (2015)[DOI]
19. Sithithaworn P, "The current status of opisthorchiasis and clonorchiasis in the Mekong Basin", Parasitol Int, 61, pp.10~16 (2012)[DOI]
20. Sithithaworn P, "Epidemiology of Opisthorchis viverrini", Acta Trop, 88, pp.187~194 (2003)[DOI]
21. Sithithaworn P, "Relationship between faecal egg count and worm burden of Opisthorchis viverrini in human autopsy cases", Parasitology, 102, pp.277~281 (1991)[DOI]
22. Kaewkes S, "Comparative studies on the morphology of the eggs of Opisthorchis viverrini and lecithodendriid trematodes", Southeast Asian J Trop Med Public Health, 22, pp.623~630 (1991)
23. 채종일, "High prevalence of liver and intestinal flukeinfections among residents of SavannakhetProvince in Laos", Parasites, Hosts and Diseases, 45(3), pp.213~218 (2007), 대한기생충학ㆍ열대의학회
24. Jin-Joo Lee, "Comparative Morphology of Minute Intestinal Fluke Eggs That Can Occur in Human Stools in the Republic of Korea", Parasites, Hosts and Diseases, 50(3), pp.207~213 (2012), 대한기생충학ㆍ열대의학회
25. Duenngai K, "Improvement of PCR for detection of Opisthorchis viverrini DNA in human stool samples", J Clin Microbiol, 46, pp.366~368 (2008)[DOI]
26. Stensvold CR, "Evaluation of PCR based coprodiagnosis of human opisthorchiasis", Acta Trop, 97, pp.26~30 (2006)[DOI]
27. Umesha KR, "Opisthorchis viverrini: detection by polymerase chain reaction (PCR) in human stool samples", Exp Parasitol, 120, pp.353~356 (2008)[DOI]
28. Tantrawatpan C, "Development of a PCR assay and pyrosequencing for identification of important human fish-borne trematodes and its potential use for detection in fecal specimens", Parasit Vectors, 7, pp.88~ (2014)[DOI]
29. Lamaningao P, "Development of a PCR assay for diagnosing trematode (Opisthorchis and Haplorchis) infections in human stools", Am J Trop Med Hyg, 96, pp.221~228 (2017)[DOI]
30. Won EJ, "Multiplex real-time PCR assay targeting eight parasites customized to the Korean population: potential use for detection in diarrheal stool samples from gastroenteritis patients", PLoS One, 11, pp.e0166957~ (2016)[DOI]
31. Lovis L, "PCR diagnosis of Opisthorchis viverrini and Haplorchis taichui infections in a Lao Community in an area of endemicity and comparison of diagnostic methods for parasitological field surveys", J Clin Microbiol, 47, pp.1517~1523 (2009)[DOI]
32. Wongratanacheewin S, "Detection of Opisthorchis viverrini in human stool specimens by PCR", J Clin Microbiol, 40, pp.3879~3880 (2002)[DOI]
33. Teimoori S, "Immunodiagnosis of opisthorchiasis using parasite cathepsin F", Parasitol Res, 114, pp.4571~4578 (2015)[DOI]
34. Sirisinha S, "Evaluation of a monoclonal antibodybased enzyme linked immunosorbent assay for the diagnosis of Opisthorchis viverrini infection in an endemic area", Am J Trop Med Hyg, 52, pp.521~524 (1995)[DOI]
35. Watwiengkam N, "Improved performance and quantitative detection of copro-antigens by a monoclonal antibody based ELISA to diagnose human opisthorchiasis", Acta Trop, 128, pp.659~665 (2013)[DOI]
36. Nie G, "Detection of Clonorchis sinensis circulating antigen in sera from Chinese patients by immunomagnetic bead ELISA based on IgY", PLoS One, 9, pp.e113208~ (2014)[DOI]
37. Worasith C, "Advances in the diagnosis of human opisthorchiasis: development of Opisthorchis viverrini antigen detection in urine", PLoS Negl Trop Dis, 9, pp.e0004157~ (2015)[DOI]
38. Sawangsoda P, "Diagnostic values of parasite-specific antibody detections in saliva and urine in comparison with serum in opisthorchiasis", Parasitol Int, 61, pp.196~202 (2012)[DOI]
39. Chaiyarit P, "Detection of salivary antibodies to crude antigens of Opisthorchis viverrini in opisthorchiasis and cholangiocarcinoma patients", Clin Oral Investig, 15, pp.477~483 (2011)[DOI]
40. Keiser J, "The drugs we have and the drugs we need against major helminth infections", Adv Parasitol, 73, pp.197~230 (2010)
41. Soukhathammavong P, "Efficacy and safety of mefloquine, artesunate, mefloquine-artesunate, tribendimidine, and praziquantel in patients with Opisthorchis viverrini: a randomised, exploratory, open-label, phase 2 trial", Lancet Infect Dis, 11, pp.110~118 (2011)[DOI]
42. Xu LL, "Efficacy and safety of praziquantel, tribendimidine and mebendazole in patients with co-infection of Clonorchis sinensis and other helminths", PLoS Negl Trop Dis, 8, pp.e3046~ (2014)[DOI]
43. Sayasone S, "Efficacy and safety of tribendimidine against Opisthorchis viverrini: two randomised, parallel-group, single-blind, dose-ranging, phase 2 trials", Lancet Infect Dis, 16, pp.1145~1153 (2016)[DOI]
44. Qian MB, "Efficacy and safety of tribendimidine against Clonorchis sinensis", Clin Infect Dis, 56, pp.e76~e82 (2013)[DOI]
45. Jusakul A, "Genetics of Opisthorchis viverrini-related cholangiocarcinoma", Curr Opin Gastroenterol, 31, pp.258~263 (2015)[DOI]
46. Sripa B, "The tumorigenic liver fluke Opisthorchis viverrini: multiple pathways to cancer", Trends Parasitol, 28, pp.395~407 (2012)[DOI]
47. Chaiyadet S, "Proteomic characterization of the internalization of Opisthorchis viverrini excretory", secretory products in human cells, 2017, pp.66, 494~502
48. Young ND, "The Opisthorchis viverrini genome provides insights into life in the bile duct", Nat Commun, 5, pp.4378~ (2014)[DOI]
49. Peng J, "The miRNAome of Opisthorchis viverrini induced intrahepatic cholangiocarcinoma", Genom Data, 2, pp.274~279 (2014)[DOI]
50. Plieskatt J, "A microRNA profile associated with Opisthorchis viverrini-induced cholangiocarcinoma in tissue and plasma", BMC Cancer, 15, pp.309~ (2015)[DOI]
51. Sripa B, "Pathobiology of opisthorchiasis: an update", Acta Trop, 88, pp.209~220 (2003)[DOI]
52. Zheng S, "Liver fluke infection and cholangiocarcinoma: a review", Parasitol Res, 116, pp.11~19 (2017)
53. Haswell-Elkins MR, "Immune responsiveness and parasite-specific antibody levels in human hepatobiliary disease associated with Opisthorchis viverrini infection", Clin Exp Immunol, 84, pp.213~218 (1991)
54. Sripa B, "Elevated plasma IL-6 associates with increased risk of advanced fibrosis and cholangiocarcinoma in individuals infected by Opisthorchis viverrini", PLoS Negl Trop Dis, 6, pp.e1654~ (2012)[DOI]
55. Sripa B, "Advanced periductal fibrosis from infection with the carcinogenic human liver fluke Opisthorchis viverrini correlates with elevated levels of interleukin-6", Hepatology, 50, pp.1273~1281 (2009)
56. Frampton G, "Interleukin-6-driven progranulin expression increases cholangiocarcinoma growth by an Akt-dependent mechanism", Gut, 61, pp.268~277 (2012)[DOI]
57. Chaiyadet S, "Excretory", secretory products of the carcinogenic liver fluke are endocytosed by human cholangiocytes and drive cell proliferation and IL6 production, 2015, pp.45, 773~781
58. Ninlawan K, "Opisthorchis viverrini excretory", secretory products induce Toll-like receptor 4 upregulation and production of interleukin 6 and 8 in cholangiocyte, 2010, pp.59, 616~621
59. Pinlaor S, "Mechanism of NO-mediated oxidative and nitrative DNA damage in hamsters infected with Opisthorchis viverrini: a model of inflammation-mediated carcinogenesis", Nitric Oxide, 11, pp.175~183 (2004)[DOI]
60. Pinlaor S, "Opisthorchis viverrini antigen induces the expression of Toll-like receptor 2 in macrophage RAW cell line", Int J Parasitol, 35, pp.591~596 (2005)[DOI]
61. Sripa B, "Localisation of parasite antigens and inflammatory responses in experimental opisthorchiasis", Int J Parasitol, 30, pp.735~740 (2000)[DOI]
62. Yan C, "Expression of Toll-like receptor (TLR) 2 and TLR4 in the livers of mice infected by Clonorchis sinensis", J Infect Dev Ctries, 9, pp.1147~1155 (2015)[DOI]
63. Maeng S, "Oxidative stress-mediated mouse liver lesions caused by Clonorchis sinensis infection", Int J Parasitol, 46, pp.195~204 (2016)[DOI]
64. Mao Q, "Clonorchis sinensis ferritin heavy chain triggers free radicals and mediates inflammation signaling in human hepatic stellate cells", Parasitol Res, 114, pp.659~670 (2015)[DOI]
65. Nam JH, "Free radicals enzymatically triggered by Clonorchis sinensis excretory-secretory products cause NF-kappaB-mediated inflammation in human cholangiocarcinoma cells", Int J Parasitol, 42, pp.103~113 (2012)[DOI]
66. Young Yil Bahk, "Toll-Like Receptor-Mediated Free Radical Generation in Clonorchis sinensis Excretory-Secretory Product-Treated Cholangiocarcinoma Cells", Parasites, Hosts and Diseases, 54(5), pp.679~684 (2016), 대한기생충학ㆍ열대의학회
67. Chaiyadet S, "Carcinogenic liver fluke secretes extracellular vesicles that promote cholangiocytes to adopt a tumorigenic phenotype", J Infect Dis, 212, pp.1636~1645 (2015)[DOI]
68. Thuwajit C, "Increased cell proliferation of mouse fibroblast NIH-3T3 in vitro induced by excretory", secretory product(s) from Opisthorchis viverrini, 2004, pp.129, 455~464
69. Thuwajit C, "Gene expression profiling defined pathways correlated with fibroblast cell proliferation induced by Opisthorchis viverrini excretory", secretory product, 2006, pp.12, 3585~3592
70. Mulvenna J, "The secreted and surface proteomes of the adult stage of the carcinogenic human liver fluke Opisthorchis viverrini", Proteomics, 10, pp.1063~1078 (2010)
71. Daorueang D, "Secreted Opisthorchis viverrini glutathione S-transferase regulates cell proliferation through AKT and ERK pathways in cholangiocarcinoma", Parasitol Int, 61, pp.155~161 (2012)[DOI]
72. Smout MJ, "A granulin-like growth factor secreted by the carcinogenic liver fluke, Opisthorchis viverrini, promotes proliferation of host cells", PLoS Pathog, 5, pp.e1000611~ (2009)[DOI]
73. Smout MJ, "Expression, refolding and purification of Ov-GRN-1, a granulin-like growth factor from the carcinogenic liver fluke, that causes proliferation of mammalian host cells", Protein Expr Purif, 79, pp.263~270 (2011)[DOI]
74. Papatpremsiri A, "Suppression of Ov-grn-1 encoding granulin of Opisthorchis viverrini inhibits proliferation of biliary epithelial cells", Exp Parasitol, 148, pp.17~23 (2015)[DOI]
75. Suttiprapa S, "Molecular expression and enzymatic characterization of thioredoxin from the carcinogenic human liver fluke Opisthorchis viverrini", Parasitol Int, 61, pp.101~106 (2012)[DOI]
76. Matchimakul P, "Apoptosis of cholangiocytes modulated by thioredoxin of carcinogenic liver fluke", Int J Biochem Cell Biol, 65, pp.72~80 (2015)[DOI]
77. Pak JH, "Differential gene expression profiling in human cholangiocarcinoma cells treated with Clonorchis sinensis excretory-secretory products", Parasitol Res, 104, pp.1035~1046 (2009)[DOI]
78. Kim YJ, "Resistance of cholangiocarcinoma cells to parthenolide-induced apoptosis by the excretory-secretory products of Clonorchis sinensis", Parasitol Res, 104, pp.1011~1016 (2009)[DOI]
79. Kim YJ, "Proliferative effects of excretory", secretory products from Clonorchis sinensis on the human epithelial cell line HEK293 via regulation of the transcription factor E2F1, 2008, pp.102, 411~417
80. Pak JH, "Induction of cancer-related microRNA expression profiling using excretory-secretory products of Clonorchis sinensis", Parasitol Res, 113, pp.4447~4455 (2014)[DOI]
81. Plieskatt JL, "Infection with the carcinogenic liver fluke Opisthorchis viverrini modifies intestinal and biliary microbiome", FASEB J, 27, pp.4572~4584 (2013)[DOI]
82. Chng KR, "Tissue Microbiome profiling identifies an enrichment of specific enteric bacteria in Opisthorchis viverrini associated cholangiocarcinoma", EBioMedicine, 8, pp.195~202 (2016)[DOI]
83. Deenonpoe R, "The carcinogenic liver fluke Opisthorchis viverrini is a reservoir for species of Helicobacter", Asian Pac J Cancer Prev, 16, pp.1751~1758 (2015)[DOI]
84. Boonyanugomol W, "Helicobacter pylori in Thai patients with cholangiocarcinoma and its association with biliary inflammation and proliferation", HPB (Oxford), 14, pp.177~184 (2012)[DOI]
85. Sripa B, "Co-infections with liver fluke and Helicobacter species: a paradigm change in pathogenesis of opisthorchiasis and cholangiocarcinoma?", Parasitol Int, 66, pp.383~389 (2017)[DOI]
86. Dangtakot R, "Coinfection with Helicobacter pylori and Opisthorchis viverrini enhances the severity of hepatobiliary abnormalities in hamsters", Infect Immun, 85, pp.e00009~e00017 (2017)
87. Pinlaor S, "iNOS-dependent DNA damage via NF-kappaB expression in hamsters infected with Opisthorchis viverrini and its suppression by the antihelminthic drug praziquantel", Int J Cancer, 119, pp.1067~1072 (2006)[DOI]
88. Pinlaor S, "Oxidative and nitrative stress in Opisthorchis viverrini-infected hamsters: an indirect effect after praziquantel treatment", Am J Trop Med Hyg, 78, pp.564~573 (2008)
89. Kamsa-Ard S, "Association between praziquantel treatment and cholangiocarcinoma: a hospital-based matched case-control study", BMC Cancer, 15, pp.776~ (2015)[DOI]
90. Hanpanich P, "Decreased risk of cholangiocarcinogenesis following repeated cycles of Opisthorchis viverrini infection-praziquantel treatment: magnetic resonance imaging (MRI) and histopathological study in a hamster model", Parasitol Int, 66, pp.464~470 (2017)[DOI]
91. Suwannatrai A, "Modeling impacts of climate change on the potential distribution of the carcinogenic liver fluke, Opisthorchis viverrini, in Thailand", Parasitol Res, 116, pp.243~250 (2017)[DOI]
92. Van CD, "Association between Opisthorchis viverrini and Leptospira spp. infection in endemic Northeast Thailand", Parasitol Int, 66, pp.503~509 (2017)[DOI]
93. Ong X, "Uncovering the pathogenic landscape of helminth (Opisthorchis viverrini) infections: a cross-sectional study on contributions of physical and social environment and healthcare interventions", PLoS Negl Trop Dis, 10, pp.e0005175~ (2016)[DOI]
94. Kim CS, "Seasonal and spatial environmental influence on Opisthorchis viverrini intermediate hosts, abundance, and distribution: insights on transmission dynamics and sustainable control", PLoS Negl Trop Dis, 10, pp.e0005121~ (2016)[DOI]
95. Kamsa-ard S, "Trends in liver cancer incidence between 1985 and 2009, Khon Kaen, Thailand: cholangiocarcinoma", Asian Pac J Cancer Prev, 12, pp.2209~2213 (2011)
96. Sripa B, "Toward integrated opisthorchiasis control in northeast Thailand: the Lawa project", Acta Trop, 141, pp.361~367 (2015)[DOI]
97. Sripa B, "The Lawa model: a sustainable, integrated opisthorchiasis control program using the EcoHealth approach in the Lawa Lake region of Thailand", Parasitol Int, 66, pp.346~354 (2017)[DOI]

관련 논문AI추천